FDA clears Roche’s Enspryng as first at-home therapy for thyroid eye disease
FDA clears Roche's Enspryng as first at-home therapy for thyroid eye disease FirstWord Pharma
Regulatory Approvals
GE HealthCare secures CE mark for MINItrace Magni cyclotron
GE HealthCare secures CE mark for MINItrace Magni cyclotron Medical Device Network
FDA clears Roche’s Enspryng for thyroid eye disease
FDA clears Roche's Enspryng for thyroid eye disease pharmaphorum
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye…
GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark
GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark MassDevice